Protagonist Therapeutics, Inc.PTGXNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Above historical average, slight contraction.
Left:
||||
Price-to-book ratio
Latest
3.52
↑ 74% above average
Average (9y)
2.02
Historical baseline
Range
High:7.18
Low:-3.62
CAGR
-7.6%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 3.52 | -9.0% |
| 2023 | 3.87 | +55.8% |
| 2022 | 2.48 | -53.0% |
| 2021 | 5.28 | +112.9% |
| 2020 | 2.48 | +8.6% |
| 2019 | 2.28 | +313.1% |
| 2018 | -1.07 | +70.4% |
| 2017 | -3.62 | -63.7% |
| 2016 | -2.21 | -130.8% |
| 2015 | 7.18 | - |